All News

An investigational vitamin D agonist significantly slowed prostate growth and improved prostate symptoms and urinary flow in men with symptomatic benign prostatic hyperplasia.

In this interview, John Barry, MD, who began his term as AUA president in May, discusses these concerns, how AUA is addressing them, and the challenges and opportunities that lie ahead.

Patients with low-risk prostate cancer, whether ulilateral or bilateral, may be considered for focal ablative therapy.

Thepractice of physicians generating revenue from imaging services to which they refer their patients has come under federal scrutiny.

S

Focal cryotherapy, defined as less than complete ablation of the prostate gland with ice, potentially offers targeted local cancer control, preserving sexual potency and urinary continence in patients whose cancer is believed to be unilaterally clinically significant.

If you determine that the life insurance you bought years ago is no longer needed to provide for a surviving family, it can be canceled or given to your favorite charitable not-for-profit entity.

Here are steps and suggestions for getting your book idea to a publisher and seeing your work in print and on the bookshelves.

You can update a past medical, family, and social history (PFS) and ROS without having to rewrite it each time.

Viable prostate cancer was detected on histologic examination of the surgical specimen from about half of patients who underwent radical cystoprostatectomy for nonprostate cancer-related disease after having received definitive radiation therapy for localized prostate cancer.

Laparoscopic radical prostatectomy for clinically localized prostate cancer is associated with very good long-term oncologic control.

An investigational gonadotropin-releasing hormone blocker produces an almost immediate reduction in the testosterone levels of patients undergoing treatment for prostate cancer.

In a trial of alpha-blocker therapy for men with newly diagnosed chronic prostatitis/chronic pelvic pain syndrome, placebo and treatment groups had the same proportion of responders: 49 percent.

A disproportionate influence of fat mass accounts for the relationship between body mass index and lower urinary tract symptoms.

Medicolegal issues in urology, discusses the impact of medical errors on the health care system and lists several goals designed to ensure your patients' safety.

Studies suggest that diet can have a significant impact on the incidence, progression, and mortality of prostate cancer.

Successfully orienting and retaining a new physician in your practice.

Young men diagnosed with prostate cancer are more likely to have aggressive disease and better progression-free survival than older men.

There are no high-level data to support current screening practices for PSA in men of any age, particularly in older men with a shorter life expectancy.

A wide array of novel targeted prostate cancer therapies are in progress or planned for the very near future.

Men who receive some form of radiotherapy for localized prostate cancer have an elevated risk of later developing bladder and rectal cancers.

Bone mineral density may increase by 6 percent or more after 1 year of bisphosphonate treatment in men who receive the therapy soon after hormone deprivation therapy is initiated and in men who have been on the therapy for a year or longer.

Research points back to the prostate as a pain generator at a time when the field has been looking away from the end organ for the pathophysiology of chronic prostatitis/chronic pelvic pain syndrome.

Long-term treatment with finasteride resulted in consistent, clinically significant reductions in total prostate volume regardless of baseline volume.

Investigators compared specific physical therapy against general, full-body, Western-style massage in men and women with interstitial cystitis/chronic pelvic pain syndrome and men with chronic prostatitis/chronic pelvic pain syndrome.

A single injection of a bacterial protoxin activated by prostate-specific antigen led to greater than 50 percent improvement in symptoms within 3 months in a preliminary clinical study of men with benign prostatic hyperplasia.

Despite a 2-year-old advisory by AUA and two leading ophthalmology groups concerning a possible complication of cataract surgery in men taking tamsulosin, awareness of the problem has failed to reach many prescribers and patients

Men facing treatment for benign prostatic hyperplasia can expect similar outcomes after transurethral resection of the prostate or photoselective vaporization of the prostate.